A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Novel Micropulse Transscleral Cyclophotocoagulation System for Clinical Treatment of Refractory Glaucoma

903 views

⸱

DOI:

10.3791/68456

⸱

October 10th, 2025

 ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

This study introduces a novel protocol for micropulse transscleral cyclophotocoagulation (MP-TSCPC) in the clinical management of refractory glaucoma. The proposed MP-TSCPC system demonstrates significant therapeutic efficacy, including substantial reduction in intraocular pressure, decreased dependence on medication, and minimized incidence of treatment-related complications.

Abstract

Traditional transscleral cyclophotocoagulation has been established as an effective intervention for refractory glaucoma. While demonstrating therapeutic efficacy, conventional TSCPC raises concerns regarding potential complications to ocular structures. In contrast, micropulse transscleral cyclophotocoagulation (MP-TSCPC) represents a significant advancement by selectively targeting pigmented epithelium to modulate aqueous humor production. This innovative approach has emerged as a well-tolerated treatment modality with reduced complication risks, supported by an increasing body of clinical evidence. This protocol details the application of a commercially available MP-TSCPC system for intraocular pressure reduction and complication mitigation in refractory glaucoma management. The procedure requires specific instrumentation, including the laser system equipped with the Micropulse Pars Plana Procedure (MP3) handpiece. Treatment efficacy and safety are governed by four critical parameters: power, duty cycle, treatment duration, and dwell time, which collectively determine the total energy delivered to the ciliary body. This paper systematically reviews the methodological framework for implementing MP-TSCPC in refractory glaucoma treatment.

Introduction

Glaucoma represents the predominant cause of irreversible vision loss globally, characterized by progressive optic neuropathy. The pathogenesis is primarily associated with sustained elevation of intraocular pressure (IOP), which induces structural damage to the optic nerve head, resulting in characteristic visual field defects and potential progression to complete vision loss1. Epidemiological projections indicate a substantial increase in global glaucoma prevalence, with estimates surpassing 100 million cases by 2040, particularly concentrated in Asian populations. China, bearing the largest glaucoma burden in Asia, reported a significant dis....

Access restricted. Please log in or start a trial to view this content.

Protocol

This protocol has been developed in strict accordance with the ethical guidelines established by the local institutional human research ethics committee, the Clinical Research Ethics Committee at Nanjing Medical University Eye Hospital. Informed consent was obtained from all participants. Ensuring compliance with all applicable regulatory standards and ethical principles governing clinical research.

1. Preparation before the treatment

NOTE: Patients with albinism are strongly advised against using MP-TSCPC. Caution should be exercised in patients with congenital/pediatric glaucoma or for those at h....

Access restricted. Please log in or start a trial to view this content.

Results

Data from the above clinical trial evaluating a novel MP-TSCPC was recently presented and is summarized in Table 1. This study included 10 patients (10 eyes) with refractory glaucoma, comprising 2 male patients (2 eyes) and 8 female patients (8 eyes). The cohort comprised 4 eyes (40%) with neovascular glaucoma, 4 eyes (40%) with chronic angle-closure glaucoma, 1 eye (10%) with open-angle glaucoma, and 1 eye (10%) with secondary glaucoma.

The mean preoperative IOP was 37.4 ± 11.......

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol establishes methodology for MP-TSCPC application in medically refractory glaucoma management, detailing perioperative workflow from preoperative preparation through initial intervention execution. The parameters for a typical treatment session are also introduced. It is important throughout the course of the parameter's determination and subsequent treatment sessions to take care that all steps of this protocol are being followed correctly, and that the patient is communicative with the operator to ensu.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgements

This work was supported by the General Project of the Natural Science Foundation of Jiangsu Basic Research Program (Grant No. BK20241738), Youth Program of the National Natural Science Foundation of China (Grant No. 82101156) and the General Project of the Basic Science Foundation (Natural science) of Jiangsu Province Ordinary Higher Education Institutions (Grant No. 1020240838).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Eyelid RetractorNanjing Beden Medical Co .NAfully expose the eyeball
GonioscopeVolk Optical IncCS002Evaluates the anterior chamber angle.
IOL-MasterCarl Zeiss MeditecModel 700Precise measurement of axial length, anterior chamber depth, and corneal curvature.
Laser ProbeIridexLP-3001Delivers laser energy to the target tissue.
Levofloxacin Eye DropsSantenNAAntibiotic eye drops to prevent postoperative infection.
Lid SpeculumKatenaSPC-3001Holds the eyelids open to expose the surgical area.
Lidocaine InjectionOtsuka Pharmaceutical Co.NAused to administer retrobulbar anesthesia
MicroPulse Laser SystemIridexMP3-1001Example: Iridex MicroPulse P3, used for cyclophotocoagulation.
Non-Contact TonometerTopconCT-800AMeasures preoperative intraocular pressure (IOP).
Ophthalmic A/B Ultrasonic ScannerSuowei Electronic Technology Co.SW-2100diagnosing eye conditions by providing precise measurements of ocular structures and detailed imaging of the eye and orbit.
Optical Coherence Tomography (OCT)Carl Zeiss MeditecCIRRUS5000Non-invasive imaging for detailed retinal layer analysis.
Povidone-Iodine SolutionJumpCanNAUsed for preoperative ocular disinfection (typically 5% concentration).
Proparacaine Eye DropsAlconNATopical anesthetic for preoperative anesthesia.
Slit Lamp MicroscopeKANGHUASLM-2ERUsed for preoperative ocular examination.
Specular MicroscopeTomey EM-3000Evaluation of corneal endothelial cell density and morphology.
Sterile Cotton SwabsMedlineSW-8001Used for disinfection and cleaning.
Sterile GlovesHalyard HealthGLV-7001Worn by the surgical team to ensure aseptic technique.
Sterile Surgical Drape3MDRN-5001Maintains a sterile surgical field.
Surgical Tape3MTAP-5001Used to secure the eye drape.
Tobramycin and Dexamethasone Eye DropsNOVARTISNASteroid eye drops to reduce postoperative inflammation.
Topcon Non-Mydriatic Retinal CameraTopconNW-400Laser scanning ophthalmoscope with multi-modal imaging capabilities.
Ultrasound Biomicroscopy (UBM)EllexUBM-5001Provides detailed imaging of the ciliary body region.
Visual Acuity ChartReichertVT-1001Used to assess preoperative visual acuity.

References

  1. Stein, J. D., Khawaja, A. P., Weizer, J. S. Glaucoma in adults-screening, diagnosis, and management: A review. JAMA. 325 (2), 164(2021).
  2. Sun, Y., et al. Disease burden of glaucoma in china: Findings from the global burden of disease 2019 study.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Micropulse CyclophotocoagulationIntraocular PressureGlaucoma TreatmentMP-TSCPC SystemPars Plana ProcedureLaser TherapyCiliary BodyOcular Complications